India Glycols Limited informed exchanges that proceedings related to its proposed business restructuring were deferred, with the next hearing date yet to be announced.
The matter came up for proceedings on May 21 in connection with the company’s restructuring plan involving Ennature Biopharma Limited and IGL Spirits Limited.
According to the company, the hearing could not take place due to lack of time before the tribunal. India Glycols added that the next hearing schedule is still awaited and further updates will be shared once received.
The proposed arrangement involves restructuring of businesses through separate resulting entities as part of the group’s broader corporate reorganisation exercise.
Under the proposed structure, Ennature Biopharma has been identified as one resulting company, while IGL Spirits has been designated as another entity under the arrangement.
The development follows earlier progress in the restructuring process linked to the group’s business realignment plans.
India Glycols operates across chemicals, spirits, nutraceuticals and specialty products businesses. The company has manufacturing operations in India and caters to both domestic and international markets across industrial and consumer-focused segments.
The company has also expanded presence in bio-based and green chemistry products over the years while diversifying operations into healthcare and beverage-related businesses.
Read More: KG Basin Case: RIL Seeks Out-of-Court Settlement with Govt, Informs SC!
As of 22 May 2026, at 9:36 AM, India Glycols Limited share price is trading at ₹1002.90 per share, reflecting a surge of 0.18% from the previous closing price.
India Glycols restructuring process involving Ennature Biopharma and IGL Spirits remains underway, with the next stage of proceedings expected after a revised hearing schedule is announced.
Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: May 22, 2026, 11:00 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
